Article info
PDFPancreas
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer
- Correspondence to Dr Volker Fendrich, Department of Surgery, Philipps University Marburg, Baldingerstrasse, D-35043 Marburg, Germany; fendrich{at}med.uni-marburg.de
Citation
The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer
Publication history
- Revised September 25, 2009
- Accepted October 14, 2009
- First published November 1, 2009.
Online issue publication
April 28, 2010
Article Versions
- Previous version (1 November 2009).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.